Certara Services Archives

Case Study

基因治疗临床试验设计中的早期价值评估

A global biotechnology company engineering precision genetic medicine for rare diseases was in need of…

Jim Gallagher2021 年 2 月 12 日

Brochure

BaseCase Interactive for Medical Affairs

Jim Gallagher2021 年 1 月 28 日

Brochure

BaseCase Market Access

Certara2020 年 11 月 30 日

Article

Getting Real with RWE

By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…

Jim Gallagher2020 年 11 月 20 日

White Paper

COVID-19 对利益相关者参与和价值传播的影响：准备迎接 New Normal

Jim Gallagher2020 年 10 月 28 日

On-Demand Webinar

SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU

In this webinar, our experts provided an overview of the SNDS and the key working…

Jim Gallagher2020 年 10 月 20 日

On-Demand Webinar

美国特定的付款压力：现状和未来融资前景

To allow for the optimal positioning of your product, portfolio, or company, it is critical…

Certara2020 年 9 月 15 日

Case Study

Reimbursement and Launch Planning

Jieun Choe2020 年 6 月 22 日

网络研讨会点播

罕见病药物困境：价值大、价格高、准入受限？

This webinar will explain how pricing has evolved for the rare disease drug market and…

webdev2020 年 2 月 19 日

Blog

Using Model-based Meta-analysis to Inform Neuropathic Pain Drug Development

Model-based Meta-analysis is a framework to compare drugs used to treat diabetic peripheral neuropathy, post-herpetic…

Leticia Arrington2019 年 12 月 19 日

Certara 服务